Your browser doesn't support javascript.
loading
[High dose therapy with autologous stem cell support--finally a progress in myelomatosis]. / Høydosebehandling med autolog stamcellestøtte--endelig et fremskritt ved myelomatose.
Wisløff, F; Tangen, J M; Brinch, L; Dahl, I M; Gruber, F X; Hammerstrøm, J; Waage, A; Nesthus, I; Ernst, P.
Affiliation
  • Wisløff F; Hematologisk avdeling Ullevål sykehus 0407 Oslo. f.g.b.wisloff@ioks.uio.no
Tidsskr Nor Laegeforen ; 121(20): 2402-6, 2001 Aug 30.
Article in Nor | MEDLINE | ID: mdl-11603051
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prednisone / Hematopoietic Stem Cell Transplantation / Antineoplastic Agents, Hormonal / Antineoplastic Agents, Alkylating / Melphalan / Multiple Myeloma Type of study: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Adult / Humans / Middle aged Language: Nor Journal: Tidsskr Nor Laegeforen Year: 2001 Document type: Article Country of publication:
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prednisone / Hematopoietic Stem Cell Transplantation / Antineoplastic Agents, Hormonal / Antineoplastic Agents, Alkylating / Melphalan / Multiple Myeloma Type of study: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Adult / Humans / Middle aged Language: Nor Journal: Tidsskr Nor Laegeforen Year: 2001 Document type: Article Country of publication: